Vulvovaginal candidiasis (VVC) is a signifi cant problem affecting 75% of all women at least once during their lifetime. Candida albicans, the causative agent in 85– 90% of these infections, is a commensal dimorphic fungus routinely found in the gastrointestinal and genitourinary tracts. Exogenous factors associated with acute VVC include modulations or imbalances in reproductive hormones caused by oral contraceptive usage, pregnancy, and hormonereplacement therapy, as well as antibiotic usage, and diabetes mellitus.